Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Rondini

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The Journal of Infectious Diseases|June 3, 2026
Immunogenicity of a Bivalent Typhoid-Paratyphoid Conjugate Vaccine Against Diverse Salmonella Paratyphi A IsolatesMartina Carducci, Eleanna Sarakinou, Luisa Massai, et al.
Frontiers in Immunology|October 31, 2024
Qualification of an enzyme-linked immunosorbent assay for quantification of anti-Vi IgG in human seraMartina Carducci, Luisa Massai, Elisa Lari, et al.
Frontiers in Immunology|November 14, 2024
Development and characterization of high-throughput serological assays to measure magnitude and functional immune response against <i>S.</i> Paratyphi A in human samplesMartina Carducci, Luisa Massai, Elisa Lari, et al.
Frontiers in Immunology|May 18, 2026
Preclinical evaluation of a bivalent conjugate vaccine against <i>Salmonella</i> Typhi and Paratyphi ARenzo Alfini, Roberta Di Benedetto, Martina Carducci, et al.
Plos Neglected Tropical Diseases|August 31, 2013
Differential epidemiology of Salmonella Typhi and Paratyphi A in Kathmandu, Nepal: a matched case control investigation in a highly endemic enteric fever settingAbhilasha Karkey, Corinne N Thompson, Nga Tran Vu Thieu, et al.
Plos One|October 8, 2011
Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adultsPierre van Damme, Froukje Kafeja, Alessandra Anemona, et al.
NPJ Vaccines|December 13, 2025
Evaluation of cross-functional antibody responses elicited by a four-component GMMA Shigella vaccineValentina Caradonna, Eleanna Sarakinou, Roberta Di Benedetto, et al.
Ebiomedicine|July 25, 2017
Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in EuropeOdile Launay, David J M Lewis, Alessandra Anemona, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup XFrancesca Micoli, Maria Rosaria Romano, Marta Tontini, et al.
The Lancet. Infectious Diseases|January 26, 2026
Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trialIlse De Coster, Mohammad AbdelGhany, Eleanna Sarakinou, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The Journal of Infectious Diseases|June 3, 2026
Immunogenicity of a Bivalent Typhoid-Paratyphoid Conjugate Vaccine Against Diverse Salmonella Paratyphi A IsolatesMartina Carducci, Eleanna Sarakinou, Luisa Massai, et al.
Frontiers in Immunology|October 31, 2024
Qualification of an enzyme-linked immunosorbent assay for quantification of anti-Vi IgG in human seraMartina Carducci, Luisa Massai, Elisa Lari, et al.
Frontiers in Immunology|November 14, 2024
Development and characterization of high-throughput serological assays to measure magnitude and functional immune response against <i>S.</i> Paratyphi A in human samplesMartina Carducci, Luisa Massai, Elisa Lari, et al.
Frontiers in Immunology|May 18, 2026
Preclinical evaluation of a bivalent conjugate vaccine against <i>Salmonella</i> Typhi and Paratyphi ARenzo Alfini, Roberta Di Benedetto, Martina Carducci, et al.
Plos Neglected Tropical Diseases|August 31, 2013
Differential epidemiology of Salmonella Typhi and Paratyphi A in Kathmandu, Nepal: a matched case control investigation in a highly endemic enteric fever settingAbhilasha Karkey, Corinne N Thompson, Nga Tran Vu Thieu, et al.
Plos One|October 8, 2011
Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adultsPierre van Damme, Froukje Kafeja, Alessandra Anemona, et al.
NPJ Vaccines|December 13, 2025
Evaluation of cross-functional antibody responses elicited by a four-component GMMA Shigella vaccineValentina Caradonna, Eleanna Sarakinou, Roberta Di Benedetto, et al.
Ebiomedicine|July 25, 2017
Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in EuropeOdile Launay, David J M Lewis, Alessandra Anemona, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup XFrancesca Micoli, Maria Rosaria Romano, Marta Tontini, et al.
The Lancet. Infectious Diseases|January 26, 2026
Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trialIlse De Coster, Mohammad AbdelGhany, Eleanna Sarakinou, et al.
Pageof 5